APT Foundation, New Haven, CT
HIV/AIDS+3 More ConditionsCHRP-BB - Other
All Sexes

Study Summary

This trial will test a new approach to preventing HIV among people who inject drugs, which includes a medication (PrEP) and a behavioral program to help people stick to the medication.

Eligible Conditions
  • Medication Adherence
  • Risky Behaviors
  • Substance Abuse

Treatment Effectiveness

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: Over a 9-month period

Over a 9-month period
HIV risk reduction behaviors
IMB measures related to PrEP adherence and HIV risk reduction
PrEP adherence

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Control Condition
1 of 2
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: CHRP-BB · No Placebo Group · N/A

Experimental Group · 1 Intervention: CHRP-BB · Intervention Types: Other
Control ConditionNoIntervention Group · 1 Intervention: Control Condition · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: over a 9-month period

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,305 Previous Clinical Trials
2,022,781 Total Patients Enrolled
APT Foundation, Inc.OTHER
5 Previous Clinical Trials
646 Total Patients Enrolled
University of ConnecticutLead Sponsor
167 Previous Clinical Trials
155,014 Total Patients Enrolled
Michael Copenhaver, PhDPrincipal Investigator - University of Connecticut
University of Connecticut
1 Previous Clinical Trials
256 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have engaged in risky behavior such as sharing needles or having unprotected sex within the last 3 months.

Frequently Asked Questions

Are there any vacancies for volunteers in this medical experiment?

"As per, this trial is actively recruiting participants since it was initially posted on September 1st 2017 and recently modified on June 7th 2022." - Anonymous Online Contributor

Unverified Answer

How many individuals can partake in this investigation at any one time?

"Affirmative. According to, the recruitment for this research project, which was posted on September 1st 2017 and most recently updated on June 7th 2022, is still ongoing. The study has a capacity of 300 participants across one site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.